157 related articles for article (PubMed ID: 37377218)
1. Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers.
Wang ZM; Zhang L; Ren DH; Zhang CY; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(2):2228899. PubMed ID: 37377218
[TBL] [Abstract][Full Text] [Related]
2. A bioinformatics analysis of the clinicopathological and prognostic significance of
Zheng HC; Ren DH; Zhang CY; Chen Y; Zhang L
J Obstet Gynaecol; 2023 Dec; 43(1):2216280. PubMed ID: 37227120
[TBL] [Abstract][Full Text] [Related]
3. The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers.
Zhang CY; Zhang L; Wang ZM; Ren DH; Zheng HC
J Obstet Gynaecol; 2023 Dec; 43(1):2213764. PubMed ID: 37218920
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers.
Zheng HC; Xue H; Zhang CY; Zhang R
J Obstet Gynaecol; 2023 Dec; 43(1):2182672. PubMed ID: 36880525
[TBL] [Abstract][Full Text] [Related]
5. BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.
Habata S; Iwasaki M; Sugio A; Suzuki M; Tamate M; Satohisa S; Tanaka R; Saito T
Int J Oncol; 2016 Jul; 49(1):402-10. PubMed ID: 27120977
[TBL] [Abstract][Full Text] [Related]
6. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
7. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells.
Suzuki M; Iwasaki M; Sugio A; Hishiya A; Tanaka R; Endo T; Takayama S; Saito T
Cancer Lett; 2011 Apr; 303(1):65-71. PubMed ID: 21316839
[TBL] [Abstract][Full Text] [Related]
8. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion.
Kassis JN; Virador VM; Guancial EA; Kimm D; Ho AS; Mishra M; Chuang EY; Cook J; Gius D; Kohn EC
J Pathol; 2009 Aug; 218(4):495-504. PubMed ID: 19402132
[TBL] [Abstract][Full Text] [Related]
9. An emerging role for BAG3 in gynaecological malignancies.
De Marco M; Falco A; Iaccarino R; Raffone A; Mollo A; Guida M; Rosati A; Chetta M; Genovese G; De Caro F; Capunzo M; Turco MC; Uversky VN; Marzullo L
Br J Cancer; 2021 Sep; 125(6):789-797. PubMed ID: 34099896
[TBL] [Abstract][Full Text] [Related]
10. The roles of
Zheng HC; Xue H; Zhang CY; Shi KH; Zhang R
Front Genet; 2022; 13():1006636. PubMed ID: 36339000
[TBL] [Abstract][Full Text] [Related]
11. BAG3 contributes to HGF-mediated cell proliferation, migration, and invasion via the Egr1 pathway in gastric cancer.
Lee JC; Koh SA; Lee KH; Kim JR
Tumori; 2019 Feb; 105(1):63-75. PubMed ID: 30514177
[TBL] [Abstract][Full Text] [Related]
12. BAG3 promotes proliferation of ovarian cancer cells via post-transcriptional regulation of Skp2 expression.
Yan J; Liu C; Jiang JY; Liu H; Li C; Li XY; Yuan Y; Zong ZH; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1668-1678. PubMed ID: 28624440
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
[TBL] [Abstract][Full Text] [Related]
14. High expression of BAG3 predicts a poor prognosis in human medulloblastoma.
Yang D; Zhou J; Wang H; Wang Y; Yang G; Zhang Y
Tumour Biol; 2016 Oct; 37(10):13215-13224. PubMed ID: 27456361
[TBL] [Abstract][Full Text] [Related]
15. microRNA-340 induces apoptosis by downregulation of BAG3 in ovarian cancer SKOV3 cells.
Qu F; Wang X
Pharmazie; 2017 Aug; 72(8):482-486. PubMed ID: 29441908
[TBL] [Abstract][Full Text] [Related]
16. BAG3 Protein Is Over-Expressed in Endometrioid Endometrial Adenocarcinomas.
Esposito V; Baldi C; Zeppa P; Festa M; Guerriero L; d'Avenia M; Chetta M; Zullo F; De Laurenzi V; Turco MC; Rosati A; Guida M
J Cell Physiol; 2017 Feb; 232(2):309-311. PubMed ID: 27414463
[TBL] [Abstract][Full Text] [Related]
17. BAG3 promotes stem cell-like phenotype in breast cancer by upregulation of CXCR4 via interaction with its transcript.
Liu BQ; Zhang S; Li S; An MX; Li C; Yan J; Wang JM; Wang HQ
Cell Death Dis; 2017 Jul; 8(7):e2933. PubMed ID: 28703799
[TBL] [Abstract][Full Text] [Related]
18. BAG3 epigenetically regulates GALNT10 expression via WDR5 and facilitates the stem cell-like properties of platin-resistant ovarian cancer cells.
Zhao FY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Liu BQ; Yan J; Li C; Wang HQ
Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119077. PubMed ID: 34111434
[TBL] [Abstract][Full Text] [Related]
19. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
Qiu S; Sun L; Jin Y; An Q; Weng C; Zheng J
Oncol Rep; 2017 Jul; 38(1):309-316. PubMed ID: 28628188
[TBL] [Abstract][Full Text] [Related]
20. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]